Atara Biotherapeutics
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2380 Conejo Spectrum St Ste 200, Thousan...Phone Number
(805) 623-4211Website
www.atarabio.comRevenue
$23.1 MillionStock Symbol
ATRAIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Atara Biotherapeutics
Founded in 2012, Atara Bio is a clinical-stage biopharmaceutical company. Atara Bio focuses on developing therapies for patients with severe and life-threatening diseases. The company is headquartered in Thousand Oaks, California.Explore more
Atara Biotherapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Atara Biotherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Atara Biotherapeutics
Click to see if Atara Biotherapeutics had a recent Job posting/layoffs
Check out if Atara Biotherapeutics is spiking on competitors!
Atara Biotherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Atara Biotherapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Atara Biotherapeutics has new funding data
Check if Atara Biotherapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Atara Biotherapeutics launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Atara Biotherapeutics
Compare insights from companies similar to Atara Biotherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Atara Biotherapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Atara Biotherapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Atara Biotherapeutics.
Atara Biotherapeutics financials insights
Gather financial insights about Atara Biotherapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Series A
$20M
Series B
$38.5M
2014
Stock Offering
$55M
2020
Stock Offering
$189.4M
2022
Debt
$31M
Atara Biotherapeutics Tech Stack
A closer look at the technologies used by Atara Biotherapeutics
See more technologies
Most Recent Scoops
Person-Based
Earnings, Finance
Left Company
Executive Move
Executive Moves, Left Company
Person-Based
Person-Based
Person-Based
Clinical Operations
Atara Biotherapeutics News & Media
Bronstein, Gewirtz & Grossman LLC Urges Atara Biotherapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
New class action for Atara (ATRA) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/22/2026ATRA EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Atara To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Atara between May 20, 2024 and January 9, 2026 and would like to discuss...Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, May 19, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Atara Biotherapeutics, Inc. ("Atara" or the "Company") (NASDAQ: ATRA) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO...Bronstein, Gewirtz & Grossman LLC Urges Atara Biotherapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
New class action for Atara (ATRA) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/22/2026
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Atara Biotherapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2012, Atara Bio is a clinical-stage biopharmaceutical company. Atara Bio focuses on developing therapies for patients with severe and life-threatening diseases. The company is headquartered in Thousand Oaks, California.... Read More
